For some of the age groups, there was evidence of a positive association with nonluminal (ER− PR−) breast cancer risk, in particular, HER2‐enriched breast cancer, whereas there was no association with triple‐negative breast cancer risk. This evidence concerns the gene ERBB2 and breast carcinoma.